Sublocade Will No Longer Be Available in Australia After December 2026
Pagsusuri ng Droga
02 Hul 2026
People who are currently on Sublocade may have heard that it will no longer be available in Australia as of 11 December 2026. We know this news is worrying, and many people will have questions about what it means for them and their loved ones.
What is happening?
The manufacturer, Indivior, has announced that Sublocade, a long-acting injectable buprenorphine, will be discontinued in Australia. Their decision is based on commercial and operational reasons. It is not because of any new concerns about the medicine’s safety, quality or effectiveness.
The last planned supply of Sublocade in Australia is 11 December 2026. Existing stock will continue to be available while supplies last, and PBS claims can continue until 31 December 2026.
What does this mean if you are receiving Sublocade?
There is still time to plan your ongoing care.
Speak with your prescribing doctor or clinic, they can work with you to discuss your options and develop a plan that meets your needs.
Will other long-acting injectable buprenorphine medicines still be available?
Yes. The current announcement only affects Sublocade.
Buvidal will continue to be available.
Need someone to talk to?
We know that changes to opioid dependence treatment can be stressful, and we know this announcement may create uncertainty for many people. Speak with your prescribing doctor or clinic about your options and next steps, and
if you need further support, your local peer-based Drug User Organisation is here to help.
| Estado o Teritoryo | Organisasyon ng Gumagamit ng Droga |
|---|---|
| Teritoryo ng Kabisera ng Australia | Canberra Alliance for Harm Minimization and Advocacy (CAHMA): (02) 6253 3643 |
| Bagong Timog Wales | NUAA’s Peerline: 1800 644 413 |
| Northern Territory | NTAHC: (08) 8944 7777 |
| Queensland | QuIVAA’s PeerQnect: 1800 175 889 |
| Timog Australia | SA Harm Reduction Peer Services (SAhrps): 1800 437 222 o (08) 83628443 |
| Tasmania | Tasmanian Users and Health Support League (TUHSL): 02 5110 000 |
| Victoria | Harm Reduction Victoria (HRVic)/Pharmacotherapy Advocacy Mediation Service (PAMS): 1800 443 844 |
| Kanlurang Australia | Peer Based Harm Reduction Western Australian (PBHR WA): (08) 9325 8387 |

Pagsusuri ng Droga
02 Hul 2026
Sublocade Will No Longer Be Available in Australia After December 2026

Pagsusuri ng Droga
02 Hul 2026
Sublocade Will No Longer Be Available in Australia After December 2026
People who are currently on Sublocade may have heard that it will no longer be available in Australia as of 11 December 2026. We know this news is worrying, and many people will have questions about what it means for them and their loved ones.

Pagsusuri ng Droga
Abril 8, 2026
Pinatahimik ng Meta at TikTok ang mga Grupo ng Pagsubok ng Pildoras Habang Dumarami ang mga Suplay ng Nakalalasong Gamot
Dapat agad na itigil ng mga kompanya ng social media ang pagsensura sa mga babala sa droga na nakapagliligtas-buhay. Maraming organisasyon, kabilang ang Pill Testing Australia, CanTEST, at ang kasosyong Know Your Stuff NZ sa New Zealand, ang nag-alis ng mga post, nasuspinde ang mga account, at sa ilang mga kaso, permanenteng binura ang mga buong pahina at personal na account, matapos i-flag ng mga automated content moderation system ang kanilang mga alerto sa pampublikong kalusugan bilang nagtataguyod ng paggamit ng droga.

Pagsusuri ng Droga
Pebrero 24, 2026
Ipinapakita ng Ulat sa Ikatlong Taon ang Tumataas na Kadalisayan ng Gamot at Nabawasang Pagpapalit habang Pinapalakas ng Serbisyo sa Pagsusuri ng Gamot sa Canberra ang Pandaigdigang Pagsubaybay
Ang unang serbisyo ng pagsusuri ng droga sa fixed-site ng Australia, ang CanTEST Health and Drug Checking Service, ay patuloy na nagpapakita ng lumalaking halaga ng pagsusuri ng droga sa kalusugan ng publiko, na nag-aambag ng mahahalagang datos ng maagang babala sa mga lokal, pambansa, at internasyonal na tugon sa mga umuusbong na panganib sa droga.
